Limerick-based genetic research firm GenCell Biosystems has signed a $12 million agreement with Brazil’s Institute of Molecular Biology of Paraná and the Fiocruz Public Health Foundation to develop new screening systems to diagnose infectious diseases in the Brazilian national public health system. The company said the new systems will use GenCell’s genetic analysis technologies and be developed over the course of two years. The first phase of the programme, which will be funded by both parties, is valued at over $12 million, but is expected to lead to “significant” follow-on sales for GenCell in Brazil.
Help employers find you! Check out all the jobs and post your resume.
